Use of Cost-Effectiveness Analysis to Determine Inventory Size for a National Cord Blood Bank

Abstract

Background. Transplantation with stem cells from stored umbilical cord blood units is an alternative to living unrelated bone marrow transplantation. The larger the inventory of stored cord units, the greater the likelihood that transplant candidates will match to a unit, but storing units is costly. The authors present the results of a study, commissioned by the Institute of Medicine, as part of a report on the establishment of a national cord blood bank, examining the optimal inventory level. They emphasize the unique challenges of undertaking cost-effectiveness analysis in this field and the contribution of the analysis to policy. Methods. The authors estimate the likelihood that transplant candidates will match to a living unrelated marrow donor or a cord blood unit as a function of cord blood inventory and then calculate the life-years gained for each transplant type by match level using historical data. They develop a model of the cord blood inventory level to estimate total costs as a function of the number of stored units. Results. The cost per life-year gained associated with increasing inventory from 50,000 to 100,000 units is $44,000 to $86,000 and from 100,000 to 150,000 units is $64,000 to $153,000, depending on the assumption about the degree to which survival rates for cord transplants vary by match quality. Conclusion. Expanding the cord blood inventory above current levels is cost-effective by conventional standards. The analysis helped shape the Institute of Medicine's report, but it is difficult to determine the extent to which the analysis influenced subsequent congressional legislation.

Keywords

cost-benefit analysis fetal blood umbilical cord blood bone marrow transplantation hematopoietic stem cell transplantation.

Get full access to this article

View all access options for this article.

References

Antman K. When are bone marrow transplants considered? Sci Am. 1996;275:124-5.

Karanes C. , Confer D. , Walker T. , Askren A. , Keller C. Unrelated donor stem cell transplantation: the role of the National Marrow Donor Program. Oncology. 2003;17:1036-8, 1043-4, 1164-7.

Committee on Establishing a National Cord Blood Stem Cell Bank Program, Institute of Medicine. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington (DC): National Academy Press; 2005 .

Mogul MJ Unrelated cord blood transplantation vs matched unrelated donor bone marrow transplantation: the risks and benefits of each choice. Bone Marrow Transplant. 2000;25(Suppl. 2): S58-60.

Howard DH , Maiers M. , Kollman C. , Logan B. , Gragert G. , Setterholm M. A cost-benefit analysis of increasing cord blood inventory levels. In: Committee on Establishing a National Cord Blood Stem Cell Bank Program, Institute of Medicine. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington (DC): National Academy Press; 2005.

Eckman MH , Sonnenberg FA , Jacoby I. , Pauker SG HLA-matched donor registries for bone marrow transplants: a decision analysis . Int J Technol Assess. 1986;2:507-31.

Kollman C. , Esteban A. , Baitty T. , et al. Assessment of optimal size and composition of the U.S. national registry of hematopoietic stem cell donors. Transplantation . 2004;78:89-95.

Mori M. , Beatty PG , Graves M. , Boucher KM , Milford EL HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation. 1997;64:1017-27.

108th Congress. House Report 108-401. Making Appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies for the Fiscal Year Ending September 30, 2004, and for Other Purposes.

10.

Beatty PG , Boucher KM , Mori M. , Milford EL Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol. 2000;61:834-40.

11.

Barker JN , Krepski TP , DeFor TE , Davies SM , Wagner JE , Weisdorf DJ Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002;8:257-60.

12.

Flomenberg N. , Baxter-Lowe LA , Confer D. , et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923-30.

13.

Appelbaum FR , Kopecky KJ Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group. Cancer. 1997;80:199-204.

14.

Arias E. United States life tables. In: National Vital Statistics Reports, Volume 52, Number 14. Hyattsville (MD): National Center for Health Statistics; 2001.

15.

Socié G. , Veum Stone J. , Wingard JR , et al. Long-term survival and late deaths after allogenic bone marrow transplantation. N Engl J Med. 1999;341:14-21.

16.

Lee SJ , Anasetti C. , Kuntz KM , Patten J. , Antin JH , Weeks JC The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia. Blood. 1998;92:4047-52.

17.

Gross domestic product deflator inflation calculator. Available from: http://www.1.jsc.nasa.gov/bu2/inflateGDP.html . Accessed 13 April 2006.

18.

nbmtLink. A resource guide for bone marrow/stem cell transplant. Available from: http://www.nbmtlink.org/rg.asp#cost. Accessed 7 September 2006 .

19.

Hirth RA , Chernew ME , Miller E. , Fendrick M. , Weissert WG Willingness to pay for a quality-adjusted life year: in search of a standard . Med Decis Making. 2000;20:332-42.

20.

Richardson Vigdor E. Coverage does matter: the value of health forgone by the uninsured. In: Committee on the Consequences of Uninsurance, Institute of Medicine. Hidden Costs, Value Lost: Uninsurance in America. Washington (DC): National Academy Press; 2003.

21.

Beatty P. , Mori M. , Milford E. Impact of racial genetic polymorphism upon the probability of finding an HLA-matched donor. Transplantation. 1995;60:778-83.

22.

Moore RF Caring for identified versus statistical lives: an evolutionary view of medical distributive justice. Ethol Sociobiol. 1996 ;17:379-401.

23.

Wallace FJ , Weingarten SR , Chiou CF , et al. The limited incorporation of economic analysis in clinical practice guidelines. J Gen Intern Med. 2002;17:210-20.